Promising UC drug trial halted early
NCT ID NCT01671956
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called bertilimumab in 32 adults with moderate to severe ulcerative colitis. The goal was to see if it could reduce disease activity compared to a placebo. The trial was terminated early, so results are limited and no clear benefit was established.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS, ACTIVE MODERATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Afula, Israel
-
Research Site
Holon, 58100, Israel
-
Research Site
Jerusalem, 91031, Israel
-
Research Site
Jerusalem, 91120, Israel
-
Research Site
Kfar Saba, 44299, Israel
-
Research Site
Tel Aviv, 64239, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.